Axon Enterprise (NASDAQ:AXON) Shares Gap Up on Strong Earnings
Axon Enterprise (NASDAQ:AXON) Shares Gap Up on Strong Earnings
Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) gapped up prior to trading on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $111.62, but opened at $119.25. Axon Enterprise shares last traded at $128.10, with a volume of 9,208 shares trading hands.
AXON企业公司(纳斯达克：AXON-GET评级)周三盘前上涨，此前该公司公布了好于预期的季度收益。该股此前收盘报111.62美元，开盘报119.25美元。Axon Enterprise股票最新报128.10美元，成交量为9,208股。
The biotechnology company reported $0.44 earnings per share for the quarter, beating analysts' consensus estimates of $0.39 by $0.05. Axon Enterprise had a net margin of 4.62% and a return on equity of 3.90%. The company had revenue of $285.61 million during the quarter, compared to the consensus estimate of $258.96 million. During the same period in the previous year, the business earned ($0.72) earnings per share. The firm's quarterly revenue was up 30.5% on a year-over-year basis.
这家生物技术公司公布本季度每股收益为0.44美元，比分析师普遍预期的0.39美元高出0.05美元。Axon Enterprise的净利润率为4.62%，股本回报率为3.90%。该公司本季度营收为2.8561亿美元，而市场普遍预期为2.5896亿美元。去年同期，该业务实现每股收益0.72美元。该公司季度营收同比增长30.5%。
Wall Street Analyst Weigh In
华尔街分析师也加入进来
A number of equities research analysts have recently weighed in on AXON shares. Northland Securities dropped their price target on shares of Axon Enterprise from $180.00 to $130.00 in a research report on Thursday, May 12th. StockNews.com upgraded shares of Axon Enterprise from a "hold" rating to a "buy" rating in a research report on Saturday, June 18th. Credit Suisse Group boosted their price objective on shares of Axon Enterprise from $134.00 to $142.00 and gave the company an "outperform" rating in a research report on Wednesday. Morgan Stanley downgraded shares of Axon Enterprise from an "overweight" rating to an "equal weight" rating and set a $120.00 price objective for the company. in a research report on Monday, May 23rd. Finally, JMP Securities restated a "buy" rating and set a $195.00 price objective on shares of Axon Enterprise in a research report on Wednesday, June 1st. One investment analyst has rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to data from MarketBeat.com, Axon Enterprise has an average rating of "Moderate Buy" and an average price target of $163.25.
许多股票研究分析师最近纷纷买入Axon股票。Northland Securities在5月12日星期四的一份研究报告中将Axon Enterprise的目标股价从180.00美元下调至130.00美元。在6月18日星期六的一份研究报告中，StockNews.com将Axon Enterprise的股票评级从持有上调至买入。瑞士信贷集团周三在一份研究报告中将Axon Enterprise的股票目标价从134.00美元上调至142.00美元，并给予该公司“跑赢大盘”的评级。摩根士丹利将Axon Enterprise的股票评级从增持下调至持平，并为该公司设定了120.00美元的目标价。在5月23日星期一的一份研究报告中。最后，JMP证券在6月1日星期三的一份研究报告中重申了“买入”评级，并为Axon Enterprise的股票设定了195.00美元的目标价。一名投资分析师对该股的评级为持有，八名分析师对该公司股票的评级为买入。根据MarketBeat.com的数据，Axon Enterprise的平均评级为“中等买入”，平均目标价为163.25美元。
Insiders Place Their Bets
内部人士下注
Institutional Trading of Axon Enterprise
Axon企业的制度性交易
Institutional investors have recently modified their holdings of the business. Prospera Financial Services Inc bought a new stake in shares of Axon Enterprise in the first quarter worth $27,000. Trust Co. of Vermont bought a new stake in Axon Enterprise in the 2nd quarter worth about $28,000. Retirement Planning Co of New England Inc. bought a new stake in Axon Enterprise in the 4th quarter worth about $31,000. Sandy Spring Bank grew its position in Axon Enterprise by 230.0% in the 2nd quarter. Sandy Spring Bank now owns 330 shares of the biotechnology company's stock worth $31,000 after purchasing an additional 230 shares in the last quarter. Finally, Tyler Stone Wealth Management bought a new stake in Axon Enterprise in the 4th quarter worth about $32,000. Institutional investors own 72.06% of the company's stock.
机构投资者最近调整了对该公司的持股。普罗斯佩拉金融服务公司在第一季度购买了价值2.7万美元的Axon Enterprise新股。佛蒙特州的Trust Co.在第二季度购买了Axon Enterprise价值约28,000美元的新股份。新英格兰公司的退休计划公司在第四季度购买了Axon Enterprise的新股份，价值约3.1万美元。沙泉银行第二季度在Axon Enterprise的持仓增加了230.0%。桑迪·斯普林银行在上个季度增持了230股桑迪-斯普林特生物科技公司的股票，目前持有330股，价值3.1万美元。最后，泰勒·斯通财富管理公司在第四季度购买了Axon Enterprise价值约3.2万美元的新股份。机构投资者持有该公司72.06%的股份。
Axon Enterprise Stock Up 12.9 %
Axon企业股票上涨12.9%
The company has a current ratio of 2.43, a quick ratio of 2.18 and a debt-to-equity ratio of 0.02. The stock's 50-day simple moving average is $97.61 and its 200-day simple moving average is $112.50. The firm has a market capitalization of $8.95 billion, a P/E ratio of 242.45 and a beta of 0.66.
该公司的流动比率为2.43，速动比率为2.18，债务权益比率为0.02。该股的50日简单移动均线切入位在97.61美元，200日简单移动均线切入位在112.50美元。该公司的市值为89.5亿美元，市盈率为242.45，贝塔系数为0.66。
Axon Enterprise Company Profile
Axon企业公司简介
(Get Rating)
(获取评级)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Axon Enterprise，Inc.在美国和国际上以泰瑟品牌开发、制造和销售导电能源设备(CED)。它通过两个部分运作，泰瑟枪和软件和传感器。该公司还提供硬件和基于云的软件解决方案，使执法部门能够捕获、安全存储、管理、共享和分析视频和其他数字证据。
Featured Stories
专题报道
- Get a free copy of the StockNews.com research report on Axon Enterprise (AXON)
- Could Rite Aid Be an Acquisition Target, Again?
- The How And Why of Investing in Oil Stocks
- The How and Why of Investing in Gold Stocks
- Workhorse Group Is Ready To Get Back On The Horse
- A Rounded Bottom In Draftkings, Inc Begins To Reverse Course
- 免费获取StockNews.com关于Axon Enterprise(Axon)的研究报告
- Rite Aid会再次成为收购目标吗？
- 投资石油股票的方式和原因
- 投资黄金股票的方式和原因
- 工作马集团准备重返赛马
- DraftKings，Inc.的圆底开始逆转
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
接受Axon企业日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收Axon Enterprise和相关公司的最新新闻和分析师评级的每日简明摘要。